A comparison of outcomes after robotic open extended thymectomy for myasthenia gravis

Cakar, Ferguel; Werner, Philipp; Augustin, Florian; Schmid, Thomas; Wolf-Magele, Astrid; Sieb, Michael; Bodner, Johannes
March 2007
European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p501
Academic Journal
Abstract: Objective: The aim of this study was to analyze the effect of the surgical approach on surgical and neurologic outcomes after extended thymectomy for myasthenia gravis. Methods: A retrospective analysis of the institutional extended thymectomies for myasthenia gravis within the last decade was performed. Patients of group A (open access by total median sternotomy; n =10; 1996–2002) and of group B (video assisted thoracoscopic surgery approach with the da Vinci robotic system; n =9; 2003–2006) did not differ with regard to gender distribution, age, body mass index, American Association of Anaesthetists score and Osserman classification of myasthenia gravis. Primary endpoints were surgical complications and the symptomatic/neurologic outcome of the extended thymectomy. Secondary endpoints were operating times and hospital stay. Results: Median follow-up was 74±23 months in group A and 13±10 months in group B. Surgical complications occurred in 4 patients in group A (requiring 2 re-interventions) and in 1 patient in group B (p <0.05). The median dose of Pyridostigminbromid was reduced 3 and 6 months postoperatively in group A to 80% and 60% of the preoperative level and in group B to 66% and 60% of the preoperative level, respectively. Within the first postoperative year all patients of group B had an improvement of their disease whereas 2 patients of group A did not benefit from thymectomy or had a worsening of symptoms. Operating times were significantly shorter in group A (110 (42–152) min vs 154 (94–312) min, p <0.05), hospital stay was significantly shorter in group B (5 (4–15) vs 10 (10–23) days, p <0.05). Conclusions: The results of this small series favour the robotic approach for extended thymectomy for myasthenia gravis in respect of both surgical and early neurologic outcome. However, prospective randomized trials are required to prove a general validity.


Related Articles

  • Total Intravenous Anesthesia Management Of A Patient With Myasthenia gravis. Sahin, Sevtap Hekimoglu; Çolak, Alkin; İnal, Mehmet; Arar, Cavidan // Internet Journal of Anesthesiology;2008, Vol. 16 Issue 1, p14 

    Myasthenia gravis is an autoimmune disease characterized by weakness and fatigability of skeletal muscles, with improvement following rest. It may be localized to specific muscle groups or it may be generalized. The peri-operative management of a patient with myasthenia gravis poses a...

  • AT A GLANCE Myasthenia gravis. Dhami, Sangeeta // GP: General Practitioner;2/3/2003, p85 

    Focuses on the disease myasthenia gravis. Description of the disease; Clinical features of the disease; Treatment of the disease.

  • A hypothesis to account for the Mary Walker phenomenon. Patten, Bernard M.; Patten, B M // Annals of Internal Medicine;Mar75, Vol. 82 Issue 3, p411 

    Certain myasthenic patients show that their skeletal muscles produce a substance during ischemic exercise which, when released into the circulation, increases muscle weakness. This phenomenon has been named after Mary Walker, the physician who popularized its demonstration. It is suggested that...

  • Videothoracoscopic thymectomy for nonthymomatous myasthenia gravis: Results of 90 patients. Toker, Alper; Tanju, Serhan; Sungur, Zerrin; Parman, Yesim; Senturk, Mert; Serdaroglu, Piraye; Dilege, Sukru; Deymeer, Feza // Surgical Endoscopy;Apr2008, Vol. 22 Issue 4, p912 

    Videothoracoscopic thymectomy is an alternative surgical procedure for patients with nonthymomatous myasthenia gravis. The aim of this study is to present our experience and to analyze the factors contributing to the operative morbidity. Ninety myasthenia gravis patients were operated through...

  • Desfluran jako vhodné inhalační anestetikum u pacientky s těžkou formou myasthenia gravis. Bicek, Vladimír; Vymazal, Tomáš // Anaesthesiology & Intensive Medicine / Anesteziologie a Intenziv;2013, Vol. 24 Issue 3, p160 

    Myasthenia gravis (MG) is a disease affecting the neuromuscular transmission. Patients show various and unpredictable sensitivity and response to non-depolarizing muscle relaxants. The risk of residual muscular blockade and postoperative respiratory failure with consequent complications is very...

  • Thoracoscopic Thymectomy. Roviaro, Giancarlo; Varoli, Federico; Vergani, Contardo; Maciocco, Marco; Crespi, Brunella; Battilana, Angelo // Seminars in Laparoscopic Surgery;Dec1997, Vol. 4 Issue 4, p219 

    Thymic pathology is conventionally approached through incisions such as thoracotomy, median sternotomy, or more limited access such as cervicotomy and partial sternotomy. Progress in videoendoscopic techniques have allowed the possibility of thoracoscopic treatment of thymic diseases. Adequate...

  • Myasthemia and me. Jones, LeAnna // RN;Jun76, Vol. 39 Issue 6, p50 

    Presents a case report on a patient with myasthenia gravis. Symptoms of myasthenia; Drug taken by patients with myasthenia; Adverse effects of the medicine.

  • Predictors of outcome of myasthenic crisis. Liu, Nan; Liu, Qi; Wu, Xiujuan; Liu, Kangding; Vadis, Quo // Neurological Sciences;May2015, Vol. 36 Issue 5, p801 

    No abstract available.

  • Myasthenia Gravis. Engel, W. King; Festoff, Barry W.; Patten, Bernard M.; Swerdlow, Michael L.; Newball, Harold H.; Thompson, Mary D. // Annals of Internal Medicine;Aug74, Vol. 81 Issue 2, p225 

    Focuses on attributes of the neuromuscular disease myasthenia gravis to dysfunction at the neuromuscular junction. Cause of the weakness of myasthenia gravis; Ultraphysiology of neuromuscular transmission; Characteristic feature of the myasthenic state; Therapeutic effect of alternate-day...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics